PubMed Health⌕ Search

Biomedical subjects

Stephane Viville

Publications and source records attributed to Stephane Viville.

4 recordsLinked to original sources

MUC4 gene polymorphism and expression in women with implantation failure.

INTRODUCTION: The molecular mechanism of human embryo implantation is poorly understood. The role of MUC4 mucin, present in endometrial epithelium, has never been explored, and results obtained in animal studies strongly suggest a role in implantation. We investigated the role of MUC4 in human embryo implantation. METHODS AND RESULTS: We analysed the MUC4 variable number of tandem repeat (VNTR) polymorphism in three populations by Southern blot analysis: spontaneously fertile patients (C), infertile patients with repeated unexplained implantation failures after IVF (IF) and patients with a child after IVF (IVF-C). We found no differences in the size or allelic distribution of MUC4 VNTR between these three populations. We also examined, in IVF-C and IF groups, the endometrial expression of MUC4 mRNA as well as the expression of the MUC4 glycoprotein together with estrogen receptor (ER) and progesterone receptor (PR). No expression differences could be detected. However, we noticed a pattern of expression for MUC4 protein, which is limited to patches of cells in the luminal and glandular epithelium. CONCLUSIONS: We conclude that the different-sized MUC4 alleles do not interfere with implantation. The absence of coexpression of MUC4 and the steroid receptors suggests that MUC4 expression is not directly regulated by steroids.

Alleles↗

Soluble HLA-G release by the human embryo: an interesting artefact?

Several publications have recently claimed that early human embryos release soluble human leukocyte antigen-G (HLA-G), and that there is a direct positive relationship between the quantity of this protein secreted and embryo quality and viability. These publications report a detection limit of 1 or 10 ng/ml of medium, and the quantity of material released was of the order of magnitude from 3 to 80 ng per day and per embryo. The protein content of a human preimplantation embryo can be estimated at 45-50 ng. This means that the HLA-G release reported could be from 10 to 100% and above the total protein content of the embryo. In recent decades, bio-industry has intensively engineered Chinese hamster ovary cells and optimized their gene expression in order to achieve extremely high yields of recombinant protein secretions reaching 50 pg per cell and per day. This is 100 times lower than what is proposed for soluble HLA-G release by the embryo. It is obvious that the embryo releases signals, but these are unlikely to be secreted at the order of magnitude of the concentrations that have been so far estimated.

Animals↗

RNA polymerase II transcription in murine cells lacking the TATA binding protein.

Inactivation of the murine TATA binding protein (TBP) gene by homologous recombination leads to growth arrest and apoptosis at the embryonic blastocyst stage. However, after loss of TBP, RNA polymerase II (pol II) remains in a transcriptionally active phosphorylation state, and in situ run-on experiments showed high levels of pol II transcription comparable to those of wild-type cells. In contrast, pol I and pol III transcription was arrested. Our results show a differential dependency of the RNA polymerases on TBP and provide evidence for TBP-independent pol II transcriptional mechanisms that allow reinitiation and maintenance of gene transcription in vivo.

Amanitins↗